Commission Decision of 28 July 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 5804) (Text with EEA relevance)

Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Decision 2008/911/EC is amended as follows: 1. Annex I is amended in accordance with Annex I to this Decision. 2. Annex II is amended in accordance with Annex II to this Decision.

Article 2

This Decision is addressed to the Member States.

Supplementary provisions

ANNEX ISupplementary provisions

ANNEX I In Annex I to Decision 2008/911/EC, the following is inserted: — ‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit), — ‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit).

ANNEX IISupplementary provisions

ANNEX II In Annex II to Decision 2008/911/EC, the following is inserted: — ‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit) ‘COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L Scientific name of the plant Calendula officinalis L. Botanical family Asteraceae Herbal substance Calendula flower Common name in all EU official languages of herbal substance — BG (bălgarski): Невен, цвят — CS (čeština): Měsíčkový květ — DA (dansk): Morgenfrueblomst — DE (Deutsch): Ringelblumenblüten — EL (elliniká): Άνθος καλέντουλας — EN (English): Calendula flower — ES (español): Flor de caléndula — ET (eesti keel): Saialilleõisik — FI (suomi): Tarhakehäkukan kukka — FR (français): Souci — HU (magyar): A körömvirág virága — IT (italiano): Calendula fiore — LT (lietuvių kalba): Medetkų žiedai — LV (latviešu valoda): Kliņģerītes ziedi — MT (malti): Fjura calendula — NL (nederlands): Goudsbloem — PL (polski): Kwiat nagietka — PT (português): Flor de calêndula — RO (română): Floare de gălbenele (calendula) — SK (slovenčina): Nechtíkový kvet — SL (slovenščina): Cvet vrtnega ognjiča — SV (svenska): Ringblomma, blomma — IS (íslenska): Morgunfrú, blóm — NO (norsk): Ringblomst Herbal preparation(s) A. Liquid extract (DER 1:1), extraction solvent ethanol 40-50 % (v/v). B. Liquid extract (DER 1:1,8-2,2), extraction solvent ethanol 40-50 % (v/v). C. Tincture (DER 1:5), extraction solvent ethanol 70-90 % (v/v). European Pharmacopoeia monograph reference Calendula flower – Calendulae flos (01/2005:1297) Indication(s) (a) Traditional herbal medicinal product for the symptomatic treatment of minor inflammations of the skin (such as sunburn) and as an aid in healing of minor wounds. (b) Traditional herbal medicinal product for the symptomatic treatment of minor inflammations in the mouth or the throat. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology”. Specified posology Herbal preparations: A. Liquid extract (DER 1:1) In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance. B. Liquid extract (DER 1:1,8-2,2) In semi-solid dosage forms: amount equivalent to 2-5 % herbal substance. C. Tincture (DER 1:5) In compresses diluted at least 1:3 with freshly boiled water. In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance. As a gargle or mouth rinse in a 2 % solution. 2 to 4 times daily Indication (a) The use is not recommended in children under 6 years of age (see below “Special warnings and precautions for use”). Indication (b) The use in children under 12 years of age is not recommended because there is no experience available (see below “Special warnings and precautions for use”). Route of administration Cutaneous and oromucosal use. Duration of use or any restrictions on the duration of use Compresses: remove after 30-60 minutes All herbal preparations: If the symptoms persist after 1 week during the use of the medicinal product a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to members of the Asteraceae ( Compositae ) family. Special warnings and precautions for use Indication (a) The use in children under 6 years of age is not recommended because there is no experience available. Indication (b) The use in children under 12 years of age is not recommended because there is no experience available. If signs of skin infection are observed, a doctor or a qualified health care practitioner should be consulted. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines Not relevant. Undesirable effects Skin sensitisation. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose None reported.’ — ‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit) ‘COMMUNITY LIST ENTRY ON PIMPINELLA ANISUM L Scientific name of the plant Pimpinella anisum L. Botanical family Apiaceae Herbal substance Aniseed Common name in all EU official languages of herbal substance — BG (bălgarski): Анасон, плод — CS (čeština): Anýzový plod — DA (dansk): Anisfrø — DE (Deutsch): Anis — EL (elliniká): Γλυκάνισο — EN (English): Aniseed — ES (español): Fruto de anís — ET (eesti keel): Aniis — FI (suomi): Anis — FR (français): Anis (fruit d) — HU (magyar): Ánizsmag — IT (italiano): Anice (Anice verde), frutto — LT (lietuvių kalba): Anyžių sėklos — LV (latviešu valoda): Anīsa sēklas — MT (malti): Frotta tal-Anisi — NL (nederlands): Anijsvrucht — PL (polski): Owoc anyżu — PT (português): Anis — RO (română): Fruct de anason — SK (slovenčina): Anízový plod — SL (slovenščina): Plod vrtnega janeža — SV (svenska): Anis — IS (íslenska): Anís — NO (norsk): Anis Herbal preparation(s) Dried aniseed, comminuted or crushed European Pharmacopoeia monograph reference Anisi fructus (01/2005:0262) Indication(s) (a) Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence. (b) Traditional herbal medicinal product used as an expectorant in cough associated with cold. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology” Specified posology Adolescents over 12 years of age, adults, elderly : Indications (a) and (b) 1 to 3,5 g of whole or (freshly ( *1 ) ) comminuted or crushed aniseed in 150 ml of boiling water as a herbal tea 3 times daily The use in children under 12 years is not recommended of age (see below “Special warnings and precautions for use”). Route of administration Oral use Duration of use or any restrictions on the duration of use Not to be taken for more than 2 weeks. If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to the active substance or to Apiaceae ( Umbelliferae ) (caraway, celery, coriander, dill and fennel) or to anethole. Special warnings and precautions for use The use is not recommended in children under 12 years of age due to the lack of adequate data for safety assessment. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation There are no data from the use of aniseed in pregnant patients. It is unknown if aniseed constituents are excreted in human breast milk. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects Allergic reactions to aniseed affecting the skin or the respiratory system may occur. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose No case of overdose has been reported. ( *1 ) For commercial preparations of comminuted or crushed aniseed the applicant must carry out appropriate stability testing related to the content of essential oil components.’

Other acts of the same type

2013/346/EU: Commission Implementing Decision of 28 June 2013 approving the plan submitted by Croatia for the approval of establishments for the purposes of intra-Union trade in poultry and hatching eggs pursuant to Council Directive 2009/158/EC (notified under document C(2013) 3988) Text with EEA relevance 2013/421/EU: Council Decision of 27 June 2013 on the position to be adopted, on behalf of the European Union within the Administrative Committee for the TIR Convention, as regards the proposal to amend the Customs Convention on the International Transport of goods under cover of TIR carnets (TIR Convention 1975)2014/941/EU: Council Decision of 27 June 2013 on the conclusion of the Agreement between the European Union and Canada on customs cooperation with respect to matters related to supply chain security 2013/329/EU: Commission Implementing Decision of 26 June 2013 providing the rules for the establishment, management and transparent functioning of the Network of national authorities or bodies responsible for health technology assessment 2013/327/EU: Commission Implementing Decision of 25 June 2013 authorising the placing on the market of food containing or consisting of genetically modified oilseed rape Ms8, Rf3 and Ms8 × Rf3, or food and feed produced from those genetically modified organisms pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2013) 3873) Text with EEA relevance 2013/333/EU: Council Decision of 25 June 2013 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 30 to the EEA Agreement, on specific provisions on the organization of cooperation in the field of statistics 2013/334/EU: Council Decision of 25 June 2013 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex XXI to the EEA Agreement 2013/335/EU: Council Decision of 25 June 2013 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Protocol 31 to the EEA Agreement, on cooperation in specific fields outside the four freedoms 2013/336/EU: Council Decision of 25 June 2013 increasing the number of Advocates-General of the Court of Justice of the European Union Council Decision 2013/306/CFSP of 24 June 2013 extending the mandate of the European Union Special Representative for Central Asia Council Decision 2013/307/CFSP of 24 June 2013 amending and extending the mandate of the European Union Special Representative for the Southern Mediterranean region 2013/313/EU: Council Implementing Decision of 21 June 2013 amending Implementing Decision 2011/77/EU on granting Union financial assistance to Ireland

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview